Clinical Trial Update: Metastatic Colorectal Cancer Patients With Long-term Response to Regorafenib

View source ↗

Summary

This clinical trial update describes long-term responses to regorafenib in patients with metastatic colorectal cancer. It highlights ongoing activity in a subse…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Stivarga (regorafenib)

Snippet

Sponsor: Bayer | Conditions: Colorectal Neoplasms | Status: COMPLETED